{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:19:04Z","timestamp":1787937544866,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.rbmo.2024.104792","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T03:05:32Z","timestamp":1745463932000},"page":"104792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Ovarian hyperstimulation syndrome \u2013 a complication of the past"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1106-3747","authenticated-orcid":false,"given":"Baris","family":"Ata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Humaidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.rbmo.2024.104792_bib0001","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1093\/humrep\/deaa257","article-title":"Haste makes waste: don't rush for a fresh embryo transfer in high responders","volume":"35","author":"Ata","year":"2020","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.rbmo.2024.104792_bib0002","doi-asserted-by":"crossref","first-page":"1168.e1","DOI":"10.1016\/j.fertnstert.2009.05.021","article-title":"High dose cabergoline in management of ovarian hyperstimulation syndrome","volume":"92","author":"Ata","year":"2009","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.rbmo.2024.104792_bib0003","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.fertnstert.2007.07.1309","article-title":"Dual renin-angiotensin blockage and total embryo cryopreservation is not a risk-free strategy in patients at high risk for ovarian hyperstimulation syndrome","volume":"90","author":"Ata","year":"2008","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.rbmo.2024.104792_bib0004","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.fertnstert.2016.04.004","article-title":"Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders","volume":"106","author":"Bar-Hava","year":"2016","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.rbmo.2024.104792_bib0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/09513590.2017.1391206","article-title":"Combined modalities for the prevention of ovarian hyperstimulation syndrome following an excessive response to stimulation","volume":"34","author":"Dahan","year":"2018","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"10.1016\/j.rbmo.2024.104792_bib0006","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"issue":"10","key":"10.1016\/j.rbmo.2024.104792_bib0007","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-Free Clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.rbmo.2024.104792_bib0008","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.fertnstert.2014.01.019","article-title":"Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and \"freeze-all\" approach in GnRH antagonist protocol","volume":"101","author":"Fatemi","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2024.104792_bib0009","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of GnRH agonist to trigger follicular maturation for in vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.rbmo.2024.104792_bib0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fendo.2017.00116","article-title":"GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF\/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis","volume":"7","author":"Haahr","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.rbmo.2024.104792_bib0011","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.rbmo.2021.03.011","article-title":"The exogenous progesterone-free luteal phase: two pilot randomized controlled trials in IVF patients","volume":"42","author":"Humaidan","year":"2021","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"10.1016\/j.rbmo.2024.104792_bib0012","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.rbmo.2024.104792_bib0013","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1472-6483(10)60612-8","article-title":"Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF\/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study","volume":"13","author":"Humaidan","year":"2006","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"10.1016\/j.rbmo.2024.104792_bib0014","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.fertnstert.2008.12.042","article-title":"1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study","volume":"93","author":"Humaidan","year":"2010","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.rbmo.2024.104792_bib0015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humupd\/dmr008","article-title":"GnRH agonist for triggering of final oocyte maturation: time for a change of practice?","volume":"17","author":"Humaidan","year":"2011","journal-title":"Hum Reprod Update"},{"issue":"9","key":"10.1016\/j.rbmo.2024.104792_bib0016","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1093\/humrep\/dew149","article-title":"Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials","volume":"31","author":"Humaidan","year":"2016","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.rbmo.2024.104792_bib0017","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/humrep\/det249","article-title":"GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.rbmo.2024.104792_bib0018","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.fertnstert.2010.03.028","article-title":"Preventing ovarian hyperstimulation syndrome: guidance for the clinician","volume":"94","author":"Humaidan","year":"2010","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.rbmo.2024.104792_bib0019","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0015-0282(16)54474-4","article-title":"Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist","volume":"56","author":"Itskovitz","year":"1991","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.rbmo.2024.104792_bib0020","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists","volume":"20","author":"Kolibianakis","year":"2005","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.rbmo.2024.104792_bib0021","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0015-0282(00)00492-1","article-title":"Distinction between early and late ovarian hyperstimulation syndrome","volume":"73","author":"Mathur","year":"2000","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.rbmo.2024.104792_bib0022","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12958-023-01113-6","article-title":"Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence","volume":"21","author":"Palomba","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"issue":"18","key":"10.1016\/j.rbmo.2024.104792_bib0023","doi-asserted-by":"crossref","first-page":"14185","DOI":"10.3390\/ijms241814185","article-title":"Beyond the Umbrella: A Systematic Review of the Interventions for the Prevention of and Reduction in the Incidence and Severity of Ovarian Hyperstimulation Syndrome in Patients Who Undergo In Vitro Fertilization Treatments","volume":"24","author":"Palomba","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.rbmo.2024.104792_bib0024","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/humupd\/dmn008","article-title":"Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome","volume":"14","author":"Soares","year":"2008","journal-title":"Hum Reprod Update"},{"issue":"2","key":"10.1016\/j.rbmo.2024.104792_bib0025","doi-asserted-by":"crossref","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI","volume":"2020","author":"Bosch","year":"2020","journal-title":"Hum Reprod Open"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648324009817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648324009817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:24:38Z","timestamp":1765499078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648324009817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1472648324009817"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2024.104792","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian hyperstimulation syndrome \u2013 a complication of the past","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2024.104792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104792"}}